Although benzene is best known as a compound that causes bone marrow d
epression leading to aplastic anemia in animals and humans, it also in
duces acute myelogenous leukemia in humans. The epidemiological eviden
ce for leukemogenesis in humans is contrasted with the results of anim
al bioassays. This review focuses on several of the problems that face
those investigators attempting to unravel the mechanism of benzene-in
duced leukemogenesis. Benzene metabolism is reviewed with the aim of s
uggesting metabolites that may play a role in the etiology of the dise
ase. The data relating to the formation of DNA adducts and their poten
tial significance are analyzed. The clastogenic activity of benzene is
discussed both in terms of biomarkers of exposure and as a potential
indication of leukemogenesis. In addition to chromosome aberrations, s
ister chromatid exchange, and micronucleus formation, the significance
of chromosomal translocations is discussed. The mutagenic activity of
benzene metabolites is reviewed and benzene is placed in perspective
as a leukemogen with other carcinogens and the lack of leukemogenic ac
tivity by compounds of related structure is noted. Finally, a pathway
from exposure to benzene to eventual leukemia is discussed in terms of
biochemical mechanisms, the role of cytokines and related factors, la
tency, and expression of leukemia.